Schizophrenia & Psychosis Action Alliance Privacy Policy

July 2024 This site is provided by Schizophrenia & Psychosis Action Alliance (S&PAA), and IRS 501(c)(3) tax-exempt non-profit organization (Tax ID 33-1213657) headquartered in Maryland. This Privacy Policy applies to the personal data provided to S&PAA when you browse this website, make a donation, register for an event, sign up for a newsletter, or otherwise […]
S&PAA Joins Schizophrenia Spectrum Biomarkers Consortium to Support Earlier Diagnosis, Development of New Treatments for Severe Brain Disease

April 5, 2023 – The Schizophrenia & Psychosis Action Alliance has joined the Schizophrenia Spectrum Biomarkers Consortium, organized by the Foundation for the National Institutes of Health to identify certain signs in the body that could help diagnose schizophrenia earlier and guide development of new treatments. Schizophrenia is one of the most disabling medical conditions, […]
New Voice of the Patient Report showcases the urgent need for better schizophrenia treatments

Feb. 7, 2023 – The Schizophrenia & Psychosis Action Alliance and its partners today released the Voice of the Patient Report, which captures the powerful stories of people living with schizophrenia and those who care for them. The report summarizes the compelling testimony provided during the Nov. 2 Externally-Led Patient-Focused Drug Development meeting on schizophrenia, […]